{"contentid": 488509, "importid": NaN, "name": "European submission for COVID-19 vaccination in children", "introduction": "The first coronavirus vaccine for children could soon be available in Europe, after Pfizer and BioNTech submitted to broaden the Conditional Marketing Authorization for their Comirnaty jab.", "content": "<p>The first coronavirus vaccine for children could soon be available in Europe, after Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX) submitted to broaden the Conditional Marketing Authorization for their Comirnaty jab.</p>\n<p>The regulatory bid comes several weeks after the firms submitted to the US Food and Drug Administration to broaden the Emergency Use Authorization (EUA) in the same way.</p>\n<p>If approved, the firms will be able to offer the coronavirus vaccine for children aged 12 to 15, with Phase III data showing the therapy is safe and effective for this age group.</p>\n<p>Pfizer and BioNTech said they plan to request additional amendments with other regulatory authorities worldwide.</p>\n<p>The European Medicines Agency's scientific panel recommended approving the jab for people over the age of 16 in late December 2020, a month after European authorities placed a bulk order for the vaccine.</p>\n<p>In early April, the European Union exercised an option under its previous agreement to order 100 million additional doses, bringing the total to 600 million.</p>\n<p>Comirnaty was the first coronavirus vaccine to receive regulatory approval, with the UK&rsquo;s Medicines and Healthcare Products Regulatory Agency (MHRA) giving its blessing towards the end of last year.</p>\n<p>Since then, the companies have continued investing in further development of the vaccine, with trials underway to test safety and efficacy in children aged six to 12.</p>\n<p>Moderna (Nasdaq: MRNA) has also begun testing its vaccine in children over 12, while a trial of AstraZeneca's (LSE: AZN) Vaxzevria in children is currently on hold, pending regulatory review of a possible link to blood clotting.</p>", "date": "2021-04-30 14:22:00", "meta_title": NaN, "meta_keywords": "children, vaccine, European, coronavirus, Pfizer, Authorization, submitted, BioNTech, broaden, Comirnaty, regulatory, COVID-, vaccination, submission, olde", "meta_description": "The first coronavirus vaccine for older children could soon be available in Europe, after Pfizer and BioNTech submitted to broaden the Conditional Marketing Aut", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-30 14:22:37", "updated": "2021-04-30 15:01:01", "access": NaN, "url": "https://www.thepharmaletter.com/article/european-submission-for-covid-19-vaccination-in-children", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "biontech_vaccine_large.jpg", "image2id": "biontech_vaccine_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Infectious diseases, Vaccines", "topic_tag": "Coronavirus, European Medicines Agency, Focus On, Public health, Regulation, Research", "geography_tag": "Europe, Germany, USA", "company_tag": "BioNTech, Pfizer", "drug_tag": "Comirnaty", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-30 14:22:00"}